Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Gladding

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
American Heart Journal|March 29, 2008
Antiplatelet drug nonresponsivenessPatrick Gladding, Mark Webster, John Ormiston, et al.
Pathology|July 17, 2021
Effect of macrotroponin on the utility of cardiac troponin I as a prognostic biomarker for long term total and cardiovascular disease mortalityLeo Lam, Leah Ha, Patrick Gladding, et al.
JACC. Cardiovascular Interventions|October 23, 2010
Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trialPatrick Gladding, Laura Panattoni, Mark Webster, et al.
Pharmacoeconomics|January 22, 2020
Correction to: The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary SyndromesLaura Panattoni, Paul M Brown, Braden Te Ao, et al.
Pharmacoeconomics|September 15, 2012
The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluationLaura Panattoni, Paul M Brown, Braden Te Ao, et al.
Personalized Medicine|May 20, 2018
A simulation of warfarin maintenance dose requirement using a pharmacogenetic algorithm in an ethnically diverse cohortPatrick Gladding, John Mackay, Irene Zeng, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Trans-fatty acids in New Zealand patients with coronary artery diseaseJocelyne R Benatar, Patrick Gladding, Harvey D White, et al.
JRSM Cardiovascular Disease|June 30, 2017
Comparison of two-dimensional strain analysis using vendor-independent and vendor-specific software in adult and pediatric patientsShafkat Anwar, Kazuaki Negishi, Allen Borowszki, et al.
Personalized Medicine|May 24, 2018
Longitudinal study of a 9p21.3 SNP using a national electronic healthcare databasePatrick Gladding, John Mackay, Mark Webster, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|September 28, 2012
Plasmonic gold and luminescent silicon nanoplatforms for multimode imaging of cancer cellsFolarin Erogbogbo, Xin Liu, Jasmine L May, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
American Heart Journal|March 29, 2008
Antiplatelet drug nonresponsivenessPatrick Gladding, Mark Webster, John Ormiston, et al.
Pathology|July 17, 2021
Effect of macrotroponin on the utility of cardiac troponin I as a prognostic biomarker for long term total and cardiovascular disease mortalityLeo Lam, Leah Ha, Patrick Gladding, et al.
JACC. Cardiovascular Interventions|October 23, 2010
Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trialPatrick Gladding, Laura Panattoni, Mark Webster, et al.
Pharmacoeconomics|January 22, 2020
Correction to: The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary SyndromesLaura Panattoni, Paul M Brown, Braden Te Ao, et al.
Pharmacoeconomics|September 15, 2012
The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluationLaura Panattoni, Paul M Brown, Braden Te Ao, et al.
Personalized Medicine|May 20, 2018
A simulation of warfarin maintenance dose requirement using a pharmacogenetic algorithm in an ethnically diverse cohortPatrick Gladding, John Mackay, Irene Zeng, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Trans-fatty acids in New Zealand patients with coronary artery diseaseJocelyne R Benatar, Patrick Gladding, Harvey D White, et al.
JRSM Cardiovascular Disease|June 30, 2017
Comparison of two-dimensional strain analysis using vendor-independent and vendor-specific software in adult and pediatric patientsShafkat Anwar, Kazuaki Negishi, Allen Borowszki, et al.
Personalized Medicine|May 24, 2018
Longitudinal study of a 9p21.3 SNP using a national electronic healthcare databasePatrick Gladding, John Mackay, Mark Webster, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|September 28, 2012
Plasmonic gold and luminescent silicon nanoplatforms for multimode imaging of cancer cellsFolarin Erogbogbo, Xin Liu, Jasmine L May, et al.
Pageof 3